WHO-We-Are

Who We Are

Capturing data on Antimicrobial resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) is an international group of expert partners, led by the International Vaccine Institute, dedicated to combatting antimicrobial resistance (AMR) in the South and South East Asian Regions. In 2018, CAPTURA was awarded grants from the Fleming Fund Phase 1 to work with countries in South and South East Asia to collect and analyse retrospective data on antimicrobial resistance AMR and antimicrobial use (AMU) in the human health sector. In 2023, CAPTURA has been awarded grants from the Fleming Fund Phase 2 to improve the quality and quantity, analysis and dissemination for use of AMR/U/C data. CAPTURA works alongside other regional AMR groups, including RADAAR and EQAsia.

What We Do

In Fleming Fund Phase 1 (2019-2023), CAPTURA has focused on expanding the volume of historical and current data on antimicrobial resistance and use in South and South East Asia. This included:

  • Identification, collection, and analysis of data from 2016-2019, to provide both regional and inter-regional context. ​
  • Capacity building activities, data processing, and network expansion, according to each country’s AMR surveillance stage. ​
  • Identifying gaps in data and areas for quality improvement that can be addressed in future initiatives to strengthen surveillance capacity. ​
  • Collaboration with in-country stakeholders to identify and assess the quality of available data on AMR/U/C in selected countries in South and Southeast Asia.​
CAPTURA-Aims

What We’ve Learned

Together with countries in South and Southeast Asia, CAPTURA has gained the following insights regarding AMR in the region:

  • In labs and pharmacies, data is often collected through paper/logbook format.
  • Generally, clinical data are not linked with lab data and pharmacy data.
  • Internal and external quality assessment (IQA, EQA) data are not readily available.
  • Regular metadata collection at the facility and national levels is infrequent.
  • Antimicrobial consumption has increased in recent years
  • Access category antibiotics are used frequently.

What we’ve accomplished

  • Identification, collection, grading, analysis, and visualization of large volumes of AMR/C/U data
  • Capacity building with WHONET to strengthen existing AMR surveillance systems
  • Enhanced understanding of laboratory and data management capacities in South and Southeast Asian countries
  • Collaboration with local governments and participating members of private sectors to collate and analyze retrospective data
  • Improved awareness towards advocacy, policy, and interventions needed to combat antimicrobial resistance and misuse
  • Dissemination of findings through workshops, country reports, and facility-level reports with specific recommendations for participating facilities and ministries
  • Learn more about CAPTURA I activities click here